FINWIRES · TerminalLIVE
FINWIRES

Austal Earnings Expected to Rise in 2027, 2028, on Back of Long-Term Order Book, Euroz Hartleys Says

By

Austal's (ASX:ASB) earnings are expected to rise in 2027 and 2028, over 2026, driven by a long-term order book, Euroz Hartleys said in a note on Monday.

It assumes an over AU$3 billion in revenue at around 8% per annum or over AU$250 million in earnings before interest and taxes (EBIT) for the best part of a decade, once mature and supported by a AU$17.7 billion order book.

US shipbuilding and Australian margins only need to be steady on increased activity to increase EBIT, Euroz Hartleys noted.

The investment firm retained its buy rating and AU$7.71 per share price target on Austral.

Related Articles

Asia

Genrix Grants CQ Pharmaceutical Distribution Rights for Myeloma Drug in China, Hong Kong, Macau, Taiwan

Chongqing Genrix Biopharmaceutical (SHA:688443) granted C.Q. Pharmaceutical (SHE:000950) subsidiary Yaoyou Pharmaceutical exclusive development and distribution rights for the GR1803 drug across China and Hong Kong, Macau, and Taiwan.The agreement covers development such as clinical trials, research, and manufacturing, as well as sales, the filing said.The GR1803 velitumimumab drug is indicated for multiple myeloma, a rare form of blood cancer.Yaoyou will pay Genrix up to 600 million yuan in initial payment, listing milestone, and technology transfer milestone payments.Genrix will also be eligible to receive sales royalties of up to a minimum percentage of two digits.

SHA:688443SHE:000950
Asia

Xuan Wu Cloud's CFO Steps Down

Xuan Wu Cloud Technology's (HKG:2392) Chief Financial Officer Ge Ping resigned to devote more time to personal affairs effective May 31, according to a Friday Hong Kong bourse filing.

HKG:2392
Asia

Update: Xi'an Eswin Materials Technology to Invest Up to 40 Million Yuan in Glassmaker's Funding Round

Xi'an Eswin Materials Technology (SHA:688783) will invest up to 40 million yuan in a pre-A+ funding round for Zhuhai Yiyuan Technology, according to a Friday filing with the Shanghai bourse.Zhuhai Yiyuan Technology seeks to raise between 100 million yuan and 200 million yuan in a funding round.The glass manufacturer plans to use the proceeds for capacity expansion, equipment procurement, and technology upgrades.

SHA:688783